Form fit function.png
Conformis, Inc. Announces Exclusive Distribution Agreement in China
23 juin 2021 07h30 HE | Conformis, Inc.
BILLERICA, Mass., June 23, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced the execution of an agreement to enter the Asia-Pacific market through an exclusive distribution...
Form fit function.png
Conformis, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
18 mai 2021 08h15 HE | Conformis, Inc.
BILLERICA, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Form fit function.png
Conformis, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference
12 mai 2021 18h10 HE | Conformis, Inc.
BILLERICA, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Form fit function.png
Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System
10 mai 2021 07h30 HE | Conformis, Inc.
BILLERICA, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee...
Form fit function.png
Conformis Reports First Quarter 2021 Financial Results
05 mai 2021 16h05 HE | Conformis, Inc.
BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Form fit function.png
Conformis Announces Achievement of Third Milestone Under Development and License Agreements
22 avr. 2021 16h30 HE | Conformis, Inc.
BILLERICA, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received 510(k) clearance by the U.S. Food and Drug Administration for patient-specific...
Form fit function.png
Conformis Announces License Agreement with Paragon 28
19 avr. 2021 16h30 HE | Conformis, Inc.
BILLERICA, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a...
Form fit function.png
Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
07 avr. 2021 07h30 HE | Conformis, Inc.
BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the...
Form fit function.png
Étude clinique : la prothèse totale de genou réalisée avec la technologie Conformis sur un patient donné est plus rentable qu'avec les implants prêts à l'emploi les plus utilisés
25 mars 2021 08h45 HE | Conformis, Inc.
BILLERICA, Mass., 25 mars 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ : CFMS) a annoncé aujourd'hui les résultats d'un examen rétrospectif indépendant de données hospitalières concluant que la...
Form fit function.png
Klinische Studie: Patientenspezifischer Kniegelenkersatz mit Conformis-Technologie ist kostengünstiger als führende gebrauchsfertige Implantate
25 mars 2021 08h45 HE | Conformis, Inc.
BILLERICA, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) hat heute bekanntgegeben, dass eine unabhängige, retrospektive Analyse von Krankenhausdaten zu dem Ergebnis...